The global Lansoprazole market was valued at US$ 362 million in 2023 and is anticipated to reach US$ 541.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Lansoprazole Market

Lansoprazole drug in this report.

North American market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Lansoprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan and Cisen Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lansoprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lansoprazole.

Report Scope

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lansoprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lansoprazole Market Report

Report Metric	Details
Report Name	Lansoprazole Market
Accounted market size in 2023	US$ 362 million
Forecasted market size in 2030	US$ 541.2 million
CAGR	6.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Capsules Tablets Injection
Segment by Application	Male Female
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan, Cisen Pharmaceutical, Lepu Pharmaceuticals, Nang Kuang Pharmaceutical, Luoxin Biotechnology, Beijing Honglin Pharma., Suzhou YUSHI Pharmaceutical Co., Changzhou Siyao Pharmaceuticals, Youcare Pharmaceutical Group, HOPE PHARMA, Sun Pharmaceutical Industries, Krka
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Lansoprazole Market growing?

Ans: The Lansoprazole Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Lansoprazole Market size in 2030?

Ans: The Lansoprazole Market size in 2030 will be US$ 541.2 million.

Who are the main players in the Lansoprazole Market report?

Ans: The main players in the Lansoprazole Market are Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, Pfizer, Taj Pharma, Mylan, Cisen Pharmaceutical, Lepu Pharmaceuticals, Nang Kuang Pharmaceutical, Luoxin Biotechnology, Beijing Honglin Pharma., Suzhou YUSHI Pharmaceutical Co., Changzhou Siyao Pharmaceuticals, Youcare Pharmaceutical Group, HOPE PHARMA, Sun Pharmaceutical Industries, Krka

What are the Application segmentation covered in the Lansoprazole Market report?

Ans: The Applications covered in the Lansoprazole Market report are Male, Female

What are the Type segmentation covered in the Lansoprazole Market report?

Ans: The Types covered in the Lansoprazole Market report are Capsules, Tablets, Injection

1 Lansoprazole Market Overview

1.1 Product Overview and Scope of Lansoprazole

1.2 Lansoprazole Segment by Type

1.2.1 Global Lansoprazole Market Value Comparison by Type (2024-2030)

1.2.2 Capsules

1.2.3 Tablets

1.2.4 Injection

1.3 Lansoprazole Segment by Application

1.3.1 Global Lansoprazole Market Value by Application: (2024-2030)

1.3.2 Male

1.3.3 Female

1.4 Global Lansoprazole Market Size Estimates and Forecasts

1.4.1 Global Lansoprazole Revenue 2019-2030

1.4.2 Global Lansoprazole Sales 2019-2030

1.4.3 Global Lansoprazole Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Lansoprazole Market Competition by Manufacturers

2.1 Global Lansoprazole Sales Market Share by Manufacturers (2019-2024)

2.2 Global Lansoprazole Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Lansoprazole Average Price by Manufacturers (2019-2024)

2.4 Global Lansoprazole Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Lansoprazole, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Lansoprazole, Product Type & Application

2.7 Lansoprazole Market Competitive Situation and Trends

2.7.1 Lansoprazole Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Lansoprazole Players Market Share by Revenue

2.7.3 Global Lansoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Lansoprazole Retrospective Market Scenario by Region

3.1 Global Lansoprazole Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Lansoprazole Global Lansoprazole Sales by Region: 2019-2030

3.2.1 Global Lansoprazole Sales by Region: 2019-2024

3.2.2 Global Lansoprazole Sales by Region: 2025-2030

3.3 Global Lansoprazole Global Lansoprazole Revenue by Region: 2019-2030

3.3.1 Global Lansoprazole Revenue by Region: 2019-2024

3.3.2 Global Lansoprazole Revenue by Region: 2025-2030

3.4 North America Lansoprazole Market Facts & Figures by Country

3.4.1 North America Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Lansoprazole Sales by Country (2019-2030)

3.4.3 North America Lansoprazole Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Lansoprazole Market Facts & Figures by Country

3.5.1 Europe Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Lansoprazole Sales by Country (2019-2030)

3.5.3 Europe Lansoprazole Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Lansoprazole Market Facts & Figures by Country

3.6.1 Asia Pacific Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Lansoprazole Sales by Country (2019-2030)

3.6.3 Asia Pacific Lansoprazole Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Lansoprazole Market Facts & Figures by Country

3.7.1 Latin America Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Lansoprazole Sales by Country (2019-2030)

3.7.3 Latin America Lansoprazole Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Lansoprazole Market Facts & Figures by Country

3.8.1 Middle East and Africa Lansoprazole Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Lansoprazole Sales by Country (2019-2030)

3.8.3 Middle East and Africa Lansoprazole Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Lansoprazole Sales by Type (2019-2030)

4.1.1 Global Lansoprazole Sales by Type (2019-2024)

4.1.2 Global Lansoprazole Sales by Type (2025-2030)

4.1.3 Global Lansoprazole Sales Market Share by Type (2019-2030)

4.2 Global Lansoprazole Revenue by Type (2019-2030)

4.2.1 Global Lansoprazole Revenue by Type (2019-2024)

4.2.2 Global Lansoprazole Revenue by Type (2025-2030)

4.2.3 Global Lansoprazole Revenue Market Share by Type (2019-2030)

4.3 Global Lansoprazole Price by Type (2019-2030)

5 Segment by Application

5.1 Global Lansoprazole Sales by Application (2019-2030)

5.1.1 Global Lansoprazole Sales by Application (2019-2024)

5.1.2 Global Lansoprazole Sales by Application (2025-2030)

5.1.3 Global Lansoprazole Sales Market Share by Application (2019-2030)

5.2 Global Lansoprazole Revenue by Application (2019-2030)

5.2.1 Global Lansoprazole Revenue by Application (2019-2024)

5.2.2 Global Lansoprazole Revenue by Application (2025-2030)

5.2.3 Global Lansoprazole Revenue Market Share by Application (2019-2030)

5.3 Global Lansoprazole Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Takeda Pharmaceutical

6.1.1 Takeda Pharmaceutical Corporation Information

6.1.2 Takeda Pharmaceutical Description and Business Overview

6.1.3 Takeda Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio

6.1.5 Takeda Pharmaceutical Recent Developments/Updates

6.2 Teva Pharms

6.2.1 Teva Pharms Corporation Information

6.2.2 Teva Pharms Description and Business Overview

6.2.3 Teva Pharms Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Teva Pharms Lansoprazole Product Portfolio

6.2.5 Teva Pharms Recent Developments/Updates

6.3 Sandoz

6.3.1 Sandoz Corporation Information

6.3.2 Sandoz Description and Business Overview

6.3.3 Sandoz Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sandoz Lansoprazole Product Portfolio

6.3.5 Sandoz Recent Developments/Updates

6.4 GSK

6.4.1 GSK Corporation Information

6.4.2 GSK Description and Business Overview

6.4.3 GSK Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GSK Lansoprazole Product Portfolio

6.4.5 GSK Recent Developments/Updates

6.5 Dr. Reddy's

6.5.1 Dr. Reddy's Corporation Information

6.5.2 Dr. Reddy's Description and Business Overview

6.5.3 Dr. Reddy's Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Dr. Reddy's Lansoprazole Product Portfolio

6.5.5 Dr. Reddy's Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer Lansoprazole Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Taj Pharma

6.6.1 Taj Pharma Corporation Information

6.6.2 Taj Pharma Description and Business Overview

6.6.3 Taj Pharma Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Taj Pharma Lansoprazole Product Portfolio

6.7.5 Taj Pharma Recent Developments/Updates

6.8 Mylan

6.8.1 Mylan Corporation Information

6.8.2 Mylan Description and Business Overview

6.8.3 Mylan Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Mylan Lansoprazole Product Portfolio

6.8.5 Mylan Recent Developments/Updates

6.9 Cisen Pharmaceutical

6.9.1 Cisen Pharmaceutical Corporation Information

6.9.2 Cisen Pharmaceutical Description and Business Overview

6.9.3 Cisen Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Cisen Pharmaceutical Lansoprazole Product Portfolio

6.9.5 Cisen Pharmaceutical Recent Developments/Updates

6.10 Lepu Pharmaceuticals

6.10.1 Lepu Pharmaceuticals Corporation Information

6.10.2 Lepu Pharmaceuticals Description and Business Overview

6.10.3 Lepu Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio

6.10.5 Lepu Pharmaceuticals Recent Developments/Updates

6.11 Nang Kuang Pharmaceutical

6.11.1 Nang Kuang Pharmaceutical Corporation Information

6.11.2 Nang Kuang Pharmaceutical Lansoprazole Description and Business Overview

6.11.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio

6.11.5 Nang Kuang Pharmaceutical Recent Developments/Updates

6.12 Luoxin Biotechnology

6.12.1 Luoxin Biotechnology Corporation Information

6.12.2 Luoxin Biotechnology Lansoprazole Description and Business Overview

6.12.3 Luoxin Biotechnology Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Luoxin Biotechnology Lansoprazole Product Portfolio

6.12.5 Luoxin Biotechnology Recent Developments/Updates

6.13 Beijing Honglin Pharma.

6.13.1 Beijing Honglin Pharma. Corporation Information

6.13.2 Beijing Honglin Pharma. Lansoprazole Description and Business Overview

6.13.3 Beijing Honglin Pharma. Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio

6.13.5 Beijing Honglin Pharma. Recent Developments/Updates

6.14 Suzhou YUSHI Pharmaceutical Co.

6.14.1 Suzhou YUSHI Pharmaceutical Co. Corporation Information

6.14.2 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Description and Business Overview

6.14.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio

6.14.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments/Updates

6.15 Changzhou Siyao Pharmaceuticals

6.15.1 Changzhou Siyao Pharmaceuticals Corporation Information

6.15.2 Changzhou Siyao Pharmaceuticals Lansoprazole Description and Business Overview

6.15.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio

6.15.5 Changzhou Siyao Pharmaceuticals Recent Developments/Updates

6.16 Youcare Pharmaceutical Group

6.16.1 Youcare Pharmaceutical Group Corporation Information

6.16.2 Youcare Pharmaceutical Group Lansoprazole Description and Business Overview

6.16.3 Youcare Pharmaceutical Group Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio

6.16.5 Youcare Pharmaceutical Group Recent Developments/Updates

6.17 HOPE PHARMA

6.17.1 HOPE PHARMA Corporation Information

6.17.2 HOPE PHARMA Lansoprazole Description and Business Overview

6.17.3 HOPE PHARMA Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.17.4 HOPE PHARMA Lansoprazole Product Portfolio

6.17.5 HOPE PHARMA Recent Developments/Updates

6.18 Sun Pharmaceutical Industries

6.18.1 Sun Pharmaceutical Industries Corporation Information

6.18.2 Sun Pharmaceutical Industries Lansoprazole Description and Business Overview

6.18.3 Sun Pharmaceutical Industries Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio

6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates

6.19 Krka

6.19.1 Krka Corporation Information

6.19.2 Krka Lansoprazole Description and Business Overview

6.19.3 Krka Lansoprazole Sales, Revenue and Gross Margin (2019-2024)

6.19.4 Krka Lansoprazole Product Portfolio

6.19.5 Krka Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Lansoprazole Industry Chain Analysis

7.2 Lansoprazole Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Lansoprazole Production Mode & Process

7.4 Lansoprazole Sales and Marketing

7.4.1 Lansoprazole Sales Channels

7.4.2 Lansoprazole Distributors

7.5 Lansoprazole Customers

8 Lansoprazole Market Dynamics

8.1 Lansoprazole Industry Trends

8.2 Lansoprazole Market Drivers

8.3 Lansoprazole Market Challenges

8.4 Lansoprazole Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

Nang Kuang Pharmaceutical

Luoxin Biotechnology

Beijing Honglin Pharma.

Suzhou YUSHI Pharmaceutical Co.

Changzhou Siyao Pharmaceuticals

Youcare Pharmaceutical Group

HOPE PHARMA

Sun Pharmaceutical Industries

Krka

List of Tables

Table 1. Global Lansoprazole Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Lansoprazole Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Lansoprazole Market Competitive Situation by Manufacturers in 2023

Table 4. Global Lansoprazole Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Lansoprazole Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Lansoprazole Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Lansoprazole Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Lansoprazole Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Lansoprazole, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Lansoprazole, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Lansoprazole, Product Type & Application

Table 12. Global Key Manufacturers of Lansoprazole, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Lansoprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lansoprazole as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Lansoprazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Lansoprazole Sales by Region (2019-2024) & (K Units)

Table 18. Global Lansoprazole Sales Market Share by Region (2019-2024)

Table 19. Global Lansoprazole Sales by Region (2025-2030) & (K Units)

Table 20. Global Lansoprazole Sales Market Share by Region (2025-2030)

Table 21. Global Lansoprazole Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Lansoprazole Revenue Market Share by Region (2019-2024)

Table 23. Global Lansoprazole Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Lansoprazole Revenue Market Share by Region (2025-2030)

Table 25. North America Lansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Lansoprazole Sales by Country (2019-2024) & (K Units)

Table 27. North America Lansoprazole Sales by Country (2025-2030) & (K Units)

Table 28. North America Lansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Lansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Lansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Lansoprazole Sales by Country (2019-2024) & (K Units)

Table 32. Europe Lansoprazole Sales by Country (2025-2030) & (K Units)

Table 33. Europe Lansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Lansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Lansoprazole Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Lansoprazole Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Lansoprazole Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Lansoprazole Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Lansoprazole Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Lansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Lansoprazole Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Lansoprazole Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Lansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Lansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Lansoprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Lansoprazole Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Lansoprazole Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Lansoprazole Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Lansoprazole Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Lansoprazole Sales (K Units) by Type (2019-2024)

Table 51. Global Lansoprazole Sales (K Units) by Type (2025-2030)

Table 52. Global Lansoprazole Sales Market Share by Type (2019-2024)

Table 53. Global Lansoprazole Sales Market Share by Type (2025-2030)

Table 54. Global Lansoprazole Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Lansoprazole Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Lansoprazole Revenue Market Share by Type (2019-2024)

Table 57. Global Lansoprazole Revenue Market Share by Type (2025-2030)

Table 58. Global Lansoprazole Price (USD/Unit) by Type (2019-2024)

Table 59. Global Lansoprazole Price (USD/Unit) by Type (2025-2030)

Table 60. Global Lansoprazole Sales (K Units) by Application (2019-2024)

Table 61. Global Lansoprazole Sales (K Units) by Application (2025-2030)

Table 62. Global Lansoprazole Sales Market Share by Application (2019-2024)

Table 63. Global Lansoprazole Sales Market Share by Application (2025-2030)

Table 64. Global Lansoprazole Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Lansoprazole Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Lansoprazole Revenue Market Share by Application (2019-2024)

Table 67. Global Lansoprazole Revenue Market Share by Application (2025-2030)

Table 68. Global Lansoprazole Price (USD/Unit) by Application (2019-2024)

Table 69. Global Lansoprazole Price (USD/Unit) by Application (2025-2030)

Table 70. Takeda Pharmaceutical Corporation Information

Table 71. Takeda Pharmaceutical Description and Business Overview

Table 72. Takeda Pharmaceutical Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Takeda Pharmaceutical Lansoprazole Product

Table 74. Takeda Pharmaceutical Recent Developments/Updates

Table 75. Teva Pharms Corporation Information

Table 76. Teva Pharms Description and Business Overview

Table 77. Teva Pharms Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Teva Pharms Lansoprazole Product

Table 79. Teva Pharms Recent Developments/Updates

Table 80. Sandoz Corporation Information

Table 81. Sandoz Description and Business Overview

Table 82. Sandoz Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Sandoz Lansoprazole Product

Table 84. Sandoz Recent Developments/Updates

Table 85. GSK Corporation Information

Table 86. GSK Description and Business Overview

Table 87. GSK Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. GSK Lansoprazole Product

Table 89. GSK Recent Developments/Updates

Table 90. Dr. Reddy's Corporation Information

Table 91. Dr. Reddy's Description and Business Overview

Table 92. Dr. Reddy's Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Dr. Reddy's Lansoprazole Product

Table 94. Dr. Reddy's Recent Developments/Updates

Table 95. Pfizer Corporation Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Pfizer Lansoprazole Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Taj Pharma Corporation Information

Table 101. Taj Pharma Description and Business Overview

Table 102. Taj Pharma Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Taj Pharma Lansoprazole Product

Table 104. Taj Pharma Recent Developments/Updates

Table 105. Mylan Corporation Information

Table 106. Mylan Description and Business Overview

Table 107. Mylan Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Mylan Lansoprazole Product

Table 109. Mylan Recent Developments/Updates

Table 110. Cisen Pharmaceutical Corporation Information

Table 111. Cisen Pharmaceutical Description and Business Overview

Table 112. Cisen Pharmaceutical Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Cisen Pharmaceutical Lansoprazole Product

Table 114. Cisen Pharmaceutical Recent Developments/Updates

Table 115. Lepu Pharmaceuticals Corporation Information

Table 116. Lepu Pharmaceuticals Description and Business Overview

Table 117. Lepu Pharmaceuticals Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Lepu Pharmaceuticals Lansoprazole Product

Table 119. Lepu Pharmaceuticals Recent Developments/Updates

Table 120. Nang Kuang Pharmaceutical Corporation Information

Table 121. Nang Kuang Pharmaceutical Description and Business Overview

Table 122. Nang Kuang Pharmaceutical Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Nang Kuang Pharmaceutical Lansoprazole Product

Table 124. Nang Kuang Pharmaceutical Recent Developments/Updates

Table 125. Luoxin Biotechnology Corporation Information

Table 126. Luoxin Biotechnology Description and Business Overview

Table 127. Luoxin Biotechnology Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Luoxin Biotechnology Lansoprazole Product

Table 129. Luoxin Biotechnology Recent Developments/Updates

Table 130. Beijing Honglin Pharma. Corporation Information

Table 131. Beijing Honglin Pharma. Description and Business Overview

Table 132. Beijing Honglin Pharma. Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Beijing Honglin Pharma. Lansoprazole Product

Table 134. Beijing Honglin Pharma. Recent Developments/Updates

Table 135. Suzhou YUSHI Pharmaceutical Co. Corporation Information

Table 136. Suzhou YUSHI Pharmaceutical Co. Description and Business Overview

Table 137. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product

Table 139. Suzhou YUSHI Pharmaceutical Co. Recent Developments/Updates

Table 140. Changzhou Siyao Pharmaceuticals Corporation Information

Table 141. Changzhou Siyao Pharmaceuticals Description and Business Overview

Table 142. Changzhou Siyao Pharmaceuticals Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. Changzhou Siyao Pharmaceuticals Lansoprazole Product

Table 144. Changzhou Siyao Pharmaceuticals Recent Developments/Updates

Table 145. Youcare Pharmaceutical Group Corporation Information

Table 146. Youcare Pharmaceutical Group Description and Business Overview

Table 147. Youcare Pharmaceutical Group Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 148. Youcare Pharmaceutical Group Lansoprazole Product

Table 149. Youcare Pharmaceutical Group Recent Developments/Updates

Table 150. HOPE PHARMA Corporation Information

Table 151. HOPE PHARMA Description and Business Overview

Table 152. HOPE PHARMA Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 153. HOPE PHARMA Lansoprazole Product

Table 154. HOPE PHARMA Recent Developments/Updates

Table 155. Sun Pharmaceutical Industries Corporation Information

Table 156. Sun Pharmaceutical Industries Description and Business Overview

Table 157. Sun Pharmaceutical Industries Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 158. Sun Pharmaceutical Industries Lansoprazole Product

Table 159. Sun Pharmaceutical Industries Recent Developments/Updates

Table 160. Krka Corporation Information

Table 161. Krka Description and Business Overview

Table 162. Krka Lansoprazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 163. Krka Lansoprazole Product

Table 164. Krka Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Lansoprazole Distributors List

Table 168. Lansoprazole Customers List

Table 169. Lansoprazole Market Trends

Table 170. Lansoprazole Market Drivers

Table 171. Lansoprazole Market Challenges

Table 172. Lansoprazole Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Lansoprazole

Figure 2. Global Lansoprazole Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Lansoprazole Market Share by Type in 2023 & 2030

Figure 4. Capsules Product Picture

Figure 5. Tablets Product Picture

Figure 6. Injection Product Picture

Figure 7. Global Lansoprazole Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Lansoprazole Market Share by Application in 2023 & 2030

Figure 9. Male

Figure 10. Female

Figure 11. Global Lansoprazole Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Lansoprazole Market Size (2019-2030) & (US$ Million)

Figure 13. Global Lansoprazole Sales (2019-2030) & (K Units)

Figure 14. Global Lansoprazole Average Price (USD/Unit) & (2019-2030)

Figure 15. Lansoprazole Report Years Considered

Figure 16. Lansoprazole Sales Share by Manufacturers in 2023

Figure 17. Global Lansoprazole Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Lansoprazole Players: Market Share by Revenue in 2023

Figure 19. Lansoprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Lansoprazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Lansoprazole Sales Market Share by Country (2019-2030)

Figure 22. North America Lansoprazole Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Lansoprazole Sales Market Share by Country (2019-2030)

Figure 26. Europe Lansoprazole Revenue Market Share by Country (2019-2030)

Figure 27. Germany Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Lansoprazole Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Lansoprazole Revenue Market Share by Region (2019-2030)

Figure 34. China Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Lansoprazole Sales Market Share by Country (2019-2030)

Figure 45. Latin America Lansoprazole Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Lansoprazole Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Lansoprazole Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Lansoprazole Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Lansoprazole by Type (2019-2030)

Figure 55. Global Revenue Market Share of Lansoprazole by Type (2019-2030)

Figure 56. Global Lansoprazole Price (USD/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Lansoprazole by Application (2019-2030)

Figure 58. Global Revenue Market Share of Lansoprazole by Application (2019-2030)

Figure 59. Global Lansoprazole Price (USD/Unit) by Application (2019-2030)

Figure 60. Lansoprazole Value Chain

Figure 61. Lansoprazole Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions